Taft Cleveland associate Allison Smith Newsome was quoted in a Bloomberg Law article, “Pfizer Copay Ruling Deals Fresh Blow to Pharma Medicare Aid,” which was published on July 27. The article discussed the Second Circuit ruling that blocked Pfizer’s proposal to help middle-income Medicare beneficiaries afford a heart drug. The ruling creates a tough regulatory barrier against pharmaceutical companies that seek to partially cover the costs of medications for patients in federal health-care programs. 

To read the article, visit here (note: subscription required). 

Newsome focuses her practice on the representation of hospitals, physician groups, and other health care organizations regarding the regulatory, transactional, and business aspects of health care law. Among other areas, she advises these clients on  regulatory matters, including HIPAA, Stark, and Anti-Kickback issues.